Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.91
01.12.21
-
01.12.22
-1.46%
11.12.21

Global_Player 
01.12.21 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
bundfuture 
28.11.21 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
me8 
01.12.21 0%
sell
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
tinelchen 
05.10.21 0%
sell
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
29.11.21
-
29.11.22
-50.07%
06.12.21

Risky Investment
thomasw 
29.11.21 50%
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.93
01.11.21
€10.80
01.11.22
-21.90%
05.12.21

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
01.11.21 50%
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
tbackenh 
15.09.21 60%
buy
Scryb Inc.

Start price
Target price
Perf. (%)
€0.42
01.04.21
€1.65
01.04.22
-68.78%
02.12.21

Bernhardow 
01.04.21 50%
buy
Knight Therapeutics

Start price
Target price
Perf. (%)
€3.50
30.11.20
€4.00
30.11.21
5.14%
01.12.21

krebskrebs 
30.11.20 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€7.40
19.11.21
-
19.11.25
1.84%
29.11.21

Gilbert 
19.11.21 50%
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€4.26
28.11.20
€5.50
28.11.21
40.85%
29.11.21

melinda 
28.11.20 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€24.27
28.11.20
-
28.11.21
-56.74%
29.11.21

Lokrim 
28.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€6.58
28.11.20
-
28.11.21
93.09%
29.11.21

Lokrim 
28.11.20 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.50
22.11.21
-
22.11.22
-2.83%
28.11.21

Risky Investment
Wolf_of_WS 
22.11.21 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€11.15
18.11.21
-
18.11.22
-5.81%
27.11.21

Risky Investment
daimler1 
18.11.21 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€21.37
22.11.21
-
22.11.22
-20.45%
27.11.21

blaugold 
22.11.21 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.75
17.11.21
€50.00
17.11.22
4.64%
27.11.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
me8 
17.11.21 0%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.97
15.11.21
-
15.11.22
-28.16%
26.11.21

Could be worthwhile Investment >10% per year
Vassago1 
15.11.21 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€13.55
14.11.21
-
14.11.22
-24.18%
26.11.21

michaelkr 
14.11.21 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€8.04
14.11.21
-
14.11.22
-9.27%
26.11.21

michaelkr 
14.11.21 50%
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€2.20
23.11.20
-
23.11.21
-26.82%
24.11.21

Wann 
23.11.20 50%
buy
Growpros Cannabis Ventures Inc

Start price
Target price
Perf. (%)
€0.13
19.11.21
-
19.11.25
2.54%
22.11.21

Gilbert 
19.11.21 50%
sell
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.25
17.11.21
€37.50
30.11.22
-19.46%
18.11.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
17.11.21 70%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.45
16.11.20
-
16.11.21
-14.81%
17.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Maxi_Scalibusa 
16.11.20 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.17
03.11.21
-
03.11.22
-8.41%
15.11.21

Risky Investment
Wolf_of_WS 
03.11.21 50%